MedTech · UK · NHS-focused

Diagnostics
at the speed
of life

The NHS can't afford to wait. Neither can patients. Heagital is bringing clinical-grade coagulation diagnostics directly to the point of care — faster answers, better decisions, right when it matters most.

PT — 12.1s
INR — 1.02
APTT — 28s
Point-of-Care Diagnostics NHS-ready pathways Coagulation Testing Tracking Application Clinical Innovation Earlier intervention Faster diagnostics Smarter decisions Point-of-Care Diagnostics NHS-ready pathwaysy Coagulation Testing Tracking Application Clinical Innovation Earlier intervention Faster diagnostics Smarter decisions
What we do

Smarter care starts with faster answers

01
Point-of-Care Coagulation Testing

From the central lab to the bedside. Our diagnostic technology cuts wait times and puts coagulation results in clinicians' hands the moment they need them — in A&E, outpatient, and community care settings.

Diagnostics
02
NHS Decision Intelligence

We turn complex NHS data into clear strategy. Our market frameworks guide procurement alignment, regional deployment, and AF registry targeting so health systems can act with confidence.

Strategy
03
Clinical Deployment Infrastructure

UKCA-compliant from the ground up. We support pilot design, clinical validation, and full NHS market entry — building the infrastructure for technology that actually reaches patients.

Infrastructure
NHS
Focused entirely on UK healthcare market entry and clinical partnerships
POCT
Bedside coagulation testing — no lab delays, no waiting, just answers
2025
UK-incorporated and advancing toward clinical deployment at pace
Our team

The people
driving Heagital

A multidisciplinary founding team combining biomedical engineering, decision science, financial strategy, and clinical systems expertise — united by a shared mission to transform diagnostics in the UK.

A
Amirreza Taqizade
CEO & Co-Founder

Biomedical engineer and entrepreneur. Founded Heagital to bring clinical-grade coagulation diagnostics to point-of-care settings. Drives the company's vision, product strategy, and clinical development roadmap.

LinkedIn
H
Hoda Rezvanjoo
Co-Founding Director & Decision Support Lead

Leads decision intelligence architecture and NHS market strategy at Heagital. Specialist in healthcare decision systems, regional deployment modelling, and UK market entry frameworks for MedTech.

LinkedIn
A
Amirhossein
CTO & Co-Founder

Leads the technical architecture and engineering direction of Heagital's diagnostic platform. Drives the product's development pathway from prototype through to clinical-grade deployment.

R
Reza Shayanfar
CFO

Oversees the financial strategy and commercial planning at Heagital. Brings rigorous financial direction to the company's fundraising, growth modelling, and NHS market investment planning.

LinkedIn

Built with purpose.
Ready to scale.

We are seeking partners — investors, NHS clinical teams, and research institutions — who believe that faster diagnostics save lives. If that's you, let's talk.

Contact

Let's build the future of diagnostics together

Whether you are an investor, an NHS clinical team, or a research institution, we welcome conversations about how Heagital can work with you.

Email
hello@heagital.com
Location
United Kingdom
Enquiries
Investment · Partnerships · Clinical trials
LinkedIn
Heagital Ltd — registered in England and Wales.
Company number: 16855753